These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Rakozy CK, Mohamed AN, Vo TD, Khatib G, Long PM, Eilender D, Palutke M. Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062 [Abstract] [Full Text] [Related]
6. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. Cancer; 2002 May 01; 94(9):2401-8. PubMed ID: 12015765 [Abstract] [Full Text] [Related]
17. Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement. Chim CS, Ma ES, Loong F, Kwong YL. J Clin Pathol; 2005 Apr 01; 58(4):443-5. PubMed ID: 15790718 [Abstract] [Full Text] [Related]
19. Blastic natural killer cell lymphoma/leukemia: a report of seven cases. Bayerl MG, Rakozy CK, Mohamed AN, Vo TD, Long M, Eilender D, Palutke M. Am J Clin Pathol; 2002 Jan 01; 117(1):41-50. PubMed ID: 11789729 [Abstract] [Full Text] [Related]